Business
Central Pharmaceutical Joint Stock Company No3: Net profit and revenue rose year-over-year, but liquidity declined due to investments and dividends
Central Pharmaceutical Joint Stock Company No3: Net profit and revenue rose year-over-year, but liquidity declined due to investments and dividends
About this update from Central Pharmaceutical Jsc No. 3
Net revenue and net profit after tax both increased year-over-year, with strong gross margins and higher equity. Significant cash outflows for investments and dividends reduced liquidity, but the company maintained stable operations in the pharmaceutical sector.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
View stock analysis, news, and events for Central Pharmaceutical Jsc No. 3